Global CustomRecombinant Protein Production Services Market, by Expression System (Mammalian, Bacteria, Insect, Yeast, andOthers), by End User (Research Institutes, Biotechnology and PharmaceuticalCompanies, Contract Research Organizations, and Others), and by Region (NorthAmerica, Latin America, Europe, Asia Pacific, Middle East, and Africa), isestimated to be valued at US$ 3,575.3 million in 2020 and is projected toexhibit a CAGR of 11.2% over the forecast period (2020 – 2027), as highlightedin a new report published by Coherent Market Insights.
Global Custom Recombinant ProteinProduction Services Market - Impact of Coronavirus (COVID-19) Pandemic
Following the COVID-19 outbreakin December 2019, the virus has spread to more than 100 countries across theglobe and the World Health Organization has declared it a public healthemergency. According to the World Health Organization’s report, themanifestation of coronavirus disease (COVID-19) has resulted in more than 29.6million infected individuals worldwide as of September 2020. The COVID-19pandemic has affected the global economy in three main ways; by directlyaffecting production and demand, by negatively impacting the supply chain andmarket disruption, and through its financial impact on firms and financialmarkets. Nationwide lockdowns in various countries such as Italy, Spain, U.K.,the U.S., Australia, India, and others have disrupted daily life andactivities.
Moreover, severe economic crisisand broken supply chain (due to Covid 19 lockdown) of bioprocessing industry isa major issue faced by bioprocessing companies in every country across theglobe. The pandemic has negatively impacted the bioprocessing industry in termsof supply and demand of biologics. As a result, the global recombinant proteinproduction services market growth is also expected to witness a slowdown.
* The sample copy includes: Report Summary, Table ofContents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/2737
The slowdown of pharma,biopharma, and biotech companies’ manufacturing processes have also impacteddemand for recombinant protein production services.
Browse 37 Market Data Tables and29 Figures spread through 190 Pages and in-depth TOC on ‘Custom RecombinantProtein Production Services Market’- Global Forecast to 2027, by ExpressionSystem (Mammalian, Bacteria, Insect, Yeast, and Others), by End User (ResearchInstitutes, Biotechnology and Pharmaceutical Companies, Contract ResearchOrganizations, and Others), and by Region (North America, Latin America,Europe, Asia Pacific, Middle East, and Africa)
The market players are focused onlaunching facilities to increase production capacity and expand their offeringsand services, which is expected to boost the market growth. For instance, inFebruary 2018, Lakepharma, Inc. established a new facility in Massachusetts tooffer fully integrated contract development and manufacturing organization(CDMO) services, thereby providing end-to-end services to partners and clients.Similarly, in February 2018, Lakepharma, Inc. launched LakePharmaMicroBiomanufacturing Center in Hopkinton, Massachusetts to enhance its abilityto offer product development and manufacturing.
Moreover, increasing expenditureon research and development is expected to boost the market growth. Forinstance, according to the National Bureau of Statistics, February 2018, China’s expenditure on research anddevelopment increased by 11.6% in 2017 from 10.6% in 2016 reaching to US$ 280Bn in 2017.
Browse ResearchReport: https://www.coherentmarketinsights.com/market-insight/custom-recombinant-protein-production-services-market-2737
Furthermore, key players in themarket are focused on adopting strategies such as collaborations andacquisitions to enhance their service offerings. For instance, in 2017,Eurofins acquired Villapharma Research SL based in Spain to expand itsportfolio of services into comprehensive offering and further strengthen itsservice proposition for the pharmaceutical and biotech industries.
Key Takeaways of the CustomRecombinant Protein Production Services Market:
The global custom recombinantprotein production services market is expected to exhibit a CAGR of 11.2% overthe forecast period. This is owing to advancements in bioreactor systems thathave reduced production time for recombinant proteins.
Among expression systems, themammalian segment is estimated to hold dominant position in the customrecombinant protein production services market in 2020. This is owing to theability of mammalian expression to offer optimized transient system for rapidyield of protein production.
Among end users, biotechnologyand pharmaceutical companies segment is estimated to hold dominant position inthe custom recombinant protein production services market in 2020, owing toincreasing number of research and development activities. According toPharmaceutical Research and Manufacturers of America (PhRMA), 2016, membercompanies invested an estimated US$ 58.8 billion in research and development in2015, which was the majority of all biopharmaceutical R&D spending in theU.S.
Key players operating in theglobal custom recombinant protein production services market include GenScriptBiotech Corporation, Applied Biological Materials Inc., Eurofins PharmaDiscovery Services, Abgent, OriGene Technologies, Inc., Crown Bioscience, Inc.,BPS Bioscience, Inc., ProteoGenix, Kempbio, Inc., Novoprotein, Premas Biotech,Trenzyme GmbH, Atum, Novus Biologicals, LLC, Icosagen AS, LakePharma, Inc.,Proteos, Inc., Aldevron, Sino Biological Inc., and SignalChem LifesciencesCorporation
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/2737
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offering action-readysyndicated research reports, custom market analysis, consulting services, andcompetitive analysis through various recommendations related to emerging markettrends, technologies, and potential absolute dollar opportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
